1Cbina National Diabetes and Metabolic Disorders Study Group. Prevalence of am diabetes among men and women in China. N Engl J Med, 2010, 362: 1090-1101.
2Meneilly GS, Tessier D. Diabetes in elderly adults. J Gerontol, 2000, 56:M5-13.
3Morrow I.A, Halter JB. Treatment of the elderly with diabetes, In:Kahn CR, Weir GC, eds. Joslin's Diabetes Mellitus. 13 th ed. Philadelphia: Lea Febinger, 1994. 552-559.
4Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med,2008,359:1577-1589.
5The action to control cardiovascular risk in diabetes study group. Effects of intensive glucose lowering in type 2 daibetes. N Engl J Med,2008,358:2545-2559.
6The ADVANVE collaborative group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med, 2008, 358: 2560-2572.
7Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications with type 2 diabetes. N Engl J Med, 2009, 360:129-139.
8Chiasson JL, Josse RG, Gomis R, et al. Acarbose, treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance. JAMA, 2003, 290:484-490.
9Qiao Q, Pyorala K, Pyorala M, et al. Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J, 2002, 23: 1267-1275.
10Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA, 2006, 295: 1681-1687.
4YangW, LuJ, WengJ, JiaW, eta1. Prevalence of diabetes among men and women in China [J]. N Engl J Med, 2010, 362 (12): 1090-1101.
5Meneilly GS, Tessier D. Diabetes in elderly adults [J]. J Gerontol A Biol Sci Med Sci, 2001, 56 (1): M5-13.
6The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus [J]. N Engl J Med, 1993, 329 (14): 977-986.
7UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [J]. Lancet, 1998, 352 (9131): 837-853.
8Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, et al. Effects of intensive glucose lowering m type 2 diabetes [J]. N Engl J Med, 2008, 358 (24): 2545-2559.
9ADVANCE Collaborative Group, Patel A, MacMahon S, et al. Intensive blood glucose control and vascular outcomes in pa- tients with type 2 diabetes [J]. N Engl J Med, 2008, 358 (24): 2560-2572.
10Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intemive glucose control in type 2 diabetes [J]. N Engl J Med, 2008, 359 (15): 1577-1589.
